The course · 11 chapters

The whole library,
in the order it helps.

Eleven chapters, each a short orientation and a link into the full guide. The sequence is the point — symptoms before testing, prevention early, coinfections after treatment, because that is the order in which each one becomes useful.

Free, no account, and nothing is saved — including how far you get. Leave and come back at whichever chapter you need.

Start reading →Browse the library instead
Chapters
11
Full guides linked
9
No account, ever
Free
Saved about you
Nothing

Chapter 1 of 11. Chapter 1

What Lyme is, and why it is so often missed

Everything after this depends on knowing what is actually being argued about. Start here even if you think you know — most of the confusion downstream comes from disagreements that are never made explicit.

Read the full guideUnderstanding TicksThe biology behind the bite.

Chapter 2 of 11. Chapter 2

The ticks themselves

Which tick, how long it was attached, and what stage it was in change what is worth doing. This is the chapter that turns a frightening event into a set of specifics.

The one that bites you is the size of a poppy seed.

The three tick life stages drawn at their true relative sizeThree life stages of the same tick, drawn to one scale so they can be compared. The larva is the smallest, has six legs, and rarely carries an infection. The nymph is roughly the size of a poppy seed and is behind most human cases. The adult is roughly the size of a sesame seed, several times larger again, and correspondingly easier to notice. The stage responsible for most illness is the one hardest to see.DRAWN TO RELATIVE SCALELarvaRarely infectedSix legsNymphMost human casesPoppy-seed sizedAdultEasier to spotSesame-seed sized

Nymphs are out when people are, and small enough to miss entirely.

Silhouettes for scale only — not an identification aid. Size varies by species and sex, and a tick that has already fed is larger than any of these.

Life stages and the poppy-seed / sesame-seed size comparisons: US Centers for Disease Control and Prevention, tick life cycle and tick identification. The three silhouettes are drawn to scale against one another; no absolute measurement is shown.

Read the full guideTick IdentificationKnow which tick you're dealing with.

Chapter 3 of 11. Chapter 3

Not getting bitten again

Placed early on purpose. It is the only part of this you fully control, and it applies to everyone in the house including the animals.

Read the full guideTick PreventionProtect yourself, your family, and your yard.

Chapter 4 of 11. Chapter 4

The rash, and what it does and does not tell you

A rash is the clearest early evidence there is — and most people never get one. Knowing both halves of that prevents the two opposite mistakes.

Read the full guideRash IdentificationRecognize the signs on your skin.

Chapter 5 of 11. Chapter 5

What the infection is doing

Read this before the testing chapter. Understanding what the infection is actually doing is what makes a test result interpretable rather than just a word on a page.

Read the full guideImmune System & LymeHow Lyme evades your defenses.

Chapter 6 of 11. Chapter 6

Testing, and why a negative is not an answer

The single most useful chapter to have read BEFORE you are handed a result. You cannot interpret a test until you know what it looks for and when it looks.

A negative first tier is the end of the path

The two-tier path a Lyme antibody test followsA blood sample goes first to a screening test that looks for antibodies. That first result branches two ways, and only one of them leads anywhere. A negative first-tier result ends the path: no second test is run on that sample. A positive or equivocal first-tier result goes on to a second tier — a Western blot or a second immunoassay — and the result is reported as positive only if both tiers agree. Because antibodies take weeks to build, a sample drawn too early can read negative in someone who is infected. Both tiers measure antibodies rather than the bacteria itself.Tier 1 — screeningLooks for antibodiesNegativeTesting stops —no Tier 2 is runPositive orequivocalGoes on to thesecond tierTier 2 —confirmationWestern blot ora second EIAResult reportedPositive only ifboth tiers agreeWhy timingmattersAntibodies takeweeks to build.A test drawn tooearly can readnegative insomeone infected.
  • The screening test everyone starts with
  • Stops at the first tier
  • Goes on to the second tier

A negative screening result ends the process — the second test is never run on that sample.

Both tiers measure your antibodies — not the bacteria itself.

Which tests are run, and how any single result is read, is a clinical decision made with a clinician. This shows the shape of the pathway, not what a result means for one person.

Two-tier serologic testing pathway: US Centers for Disease Control and Prevention, Lyme disease diagnosis and testing. No interval, count or proportion on this drawing is a measured quantity — "weeks" is qualitative and deliberately unquantified.

Read the full guideTesting GuideHow the tests work, and why timing decides everything.

Chapter 7 of 11. Chapter 7

Why it is rarely just Lyme

Placed after testing because this is the usual answer when treatment is not working and nobody can say why. Babesia is a parasite rather than a bacterium; Bartonella is missed routinely. A single tick transmits all of them at once.

Read the full guideCoinfectionsWhy Lyme is rarely just Lyme — and why that matters when treatment stalls.

Chapter 8 of 11. Chapter 8

What treatment looks like

There is no single correct protocol, and the honest version of this chapter is a map rather than a recommendation. What is right depends on things only you and a clinician can weigh.

Two sets of guidance, and where they part

Three questions, and what each set of guidance says in answer to them.

Where two sets of tick-borne disease guidance differTwo sets of guidance answer the same questions differently, and neither is presented as the settled answer. On how long to treat, IDSA and CDC guidance describes a defined course and holds that longer courses have no proven benefit, while ILADS guidance allows longer or repeated courses, decided case by case. On whether infection can persist, IDSA and CDC guidance holds that persistence is not established and calls continuing illness post-treatment syndrome, while ILADS guidance considers persistence possible and says it may explain ongoing symptoms. On how much the test decides, IDSA and CDC guidance has serology guide the diagnosis, with two-tier testing as the standard, while ILADS guidance allows the clinical picture to outweigh the test, given known test limitations. Both positions are held by practising clinicians.IDSA / CDCguidanceILADSguidanceHow long to treatA defined courseLonger courses:no proven benefitLonger orrepeated coursesDecidedcase by caseWhether infection can persistNot establishedCalled post-treatmentsyndromeConsideredpossibleAnd may explainongoing symptomsHow much the test decidesSerology guidesdiagnosisTwo-tier testingis the standardClinical picturecan outweigh itGiven known testlimitations

Both columns are the same size, in the same type, in the same colour. That is deliberate: this figure records a disagreement; it does not settle one.

Knowing which of the three questions is actually in front of you — how long, whether it persists, or how much the test decides — is what makes the next conversation a shorter one.

Both positions are held by practising clinicians. This shows where they differ; it is not a recommendation. Your treatment is a conversation with your own clinician.

Orientation only. No figure on this drawing is a measured quantity: the columns paraphrase the shape of two published positions in plain language, and carry no dose, no duration and no guideline version.

Read the full guideTreatment ProtocolsStandard-of-care approaches, explained.

Chapter 9 of 11. Chapter 9

Integrative approaches, and what the evidence says

Widely used and unevenly studied. The point of this chapter is to be able to tell those two things apart — including where the honest answer is that nobody has looked.

Read the full guideIntegrative ApproachesWhat patients use — with honest evidence.

Chapter 10 of 11. Chapter 10

Alpha-gal and food safety

A different tick-borne condition entirely, and one that gets missed for years because nobody connects a bite to a reaction that happens hours after dinner.

Read the full guideAlpha-gal Food SafetyThe meat allergy — hidden sources & swaps.

Chapter 11 of 11. Chapter 11

Advocating for yourself

The chapter with no article behind it, because it is not medical. It is about records, appeals, and how to be believed — which for this illness is a skill you are forced to learn.

Glossary

The words you are expected to already know

Not knowing these is a large part of why appointments go badly. Each one defines a term — what a result means for you is a conversation with your clinician.

Two-tier testing
The standard approach: a first antibody test, then a second confirmatory one. Both look for your immune response rather than for the bacterium itself.
Serology
Any test that looks for antibodies in blood. It measures your response to an infection, which is why timing changes what it can find. "Seronegative" means no antibodies were detected.
Western blot
The confirmatory test in the standard pair. It reports antibodies to individual proteins as "bands" — separate markers that are read together rather than individually.
Seroconversion
The moment your antibody levels become high enough to detect. Before it, a test can be negative while an infection is present.
Coinfection
A second organism transmitted by the same tick in the same bite. Different organism, different illness, often different treatment.
Herxheimer reaction
A temporary worsening some people notice after starting or changing treatment. What it means in any individual case is a question for their clinician.
EM rash
Erythema migrans — the expanding rash sometimes called a bull’s-eye. Present in some cases and absent in many.
Vector
The organism that carries an infection between hosts. For Lyme, the tick.
Nymph
A juvenile tick stage. Small enough to be missed easily, which is part of why bites often go unnoticed.
Prophylaxis
Treatment given to prevent an infection rather than to treat a confirmed one. Whether it applies is a clinical judgement.

Questions

About this course

Knowledge check

Five questions about what you just read

These check the material, not you. Getting one wrong means a chapter did not land — the explanation is the point, and it appears either way.

  1. Someone tests negative on the standard two-tier test. What does that establish?

  2. Which of these is caused by a parasite rather than a bacterium?

  3. A dog in the household tests C6 positive. What does that tell the people who live there?

  4. What is a Herxheimer reaction?

  5. Why does the order of these chapters put symptoms before testing?

What this covered

  • What Lyme is, and why it is argued about
  • The ticks, and which one matters
  • Not getting bitten again
  • The rash, and what it does not tell you
  • What the infection is doing
  • Testing, and why a negative is not an answer
  • Why it is rarely just Lyme
  • What treatment looks like
  • Integrative approaches and the evidence
  • Alpha-gal, a different tick-borne illness
  • Advocating for yourself

Where to go next